Drs Camidge and Rimel spotlight Dr Rimel’s career journey and the work she does to expand medical care for transgender patients.
BJ Rimel, MD
Advertisement
Articles by BJ Rimel, MD
BJ Rimel, MD, discuss the current literature surrounding antiangiogenesis agents in ovarian cancer.
Advertisement
Latest Updated Articles
Antiangiogenesis Agents in Ovarian CancerMarch 29th 2015
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to BI-1808 Plus Pembrolizumab in Ovarian Cancer
2
FDA Flashback: Breast Cancer Decisions and News From July 2026
3
FDA Grants Accelerated Approval to RP1 Plus Nivolumab for Advanced Melanoma After Anti–PD-1 Therapy
4
Dr Brufsky on the FDA Approval of Gedatolisib Plus Fulvestrant ± Palbociclib in PIK3CA Wild-Type Breast Cancer
5